RecallDepth
Class II Ongoing

Lorazepam Injection, USP, 2 mg/mL, 25 x 1mL vials/carton, Rx Only, Manufactured by: Hikma Berkeley Heights, NJ 07922, NDC# 0641-6044-25

Company
Hikma Pharmaceuticals Usa Inc.
Recall Initiated
July 22, 2025
Posted
August 6, 2025
Recall Number
D-0551-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
382,775 1mL vials
Firm Location
Cherry Hill, NJ, United States

Reason for Recall

Failed Impurities/Degradation Specifications: An out-of-Specification for total related compounds

Distribution

Distributed Nationwide in the USA

Lot / Code Info

Lot # K24118, exp. date 10/31/2026

More recalls by Hikma Pharmaceuticals Usa Inc.

View all recalls by this company →

Other recent Class II Drug recalls